Analgesics in the Netherlands

Date: November 30, 2017
Pages: 18
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A9544652252EN
Leaflet:

Download PDF Leaflet

Analgesics is expected to record a relatively strong increase in sales over the forecast period, with growth rates set to be well in excess of what was recorded over the review period. Greater consumer confidence in OTC analgesics due to tighter regulatory restrictions and the increasing trend of self-medication for minor ailments are expected to result in a value CAGR of 3% at constant 2017 prices. Nevertheless, sales are likely to be suppressed somewhat by the cautious attitudes that many Dutc...

Euromonitor International's Analgesics in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Growth Set To Accelerate Over the Forecast Period
Restrictions on the Retail Sale of OTC Analgesics Pose Threat To Growth
Value Growth Set To Be Spurred by the Category's Leading International Brands
Competitive Landscape
Major International Manufacturers and Chained Retailers With Private Label in the Lead
Multinational Players Dominate Sales
Private Label Remains A Force To Be Reckoned With
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Positive Value Growth Remains A Constant for Consumer Health
Weather Conditions Continue To Influence Sales Trends in Consumer Health
Multinational Companies Remain Dominant As Smaller Players Gain Ground
Changing Shopping Habits Spur the Evolution of the Retail Environment
Consistently Positive Value Growth Expected Over the Forecast Period
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources












Skip to top


Analgesics - Netherlands US$ 990.00 Jun, 2010 · 35 pages
Adult Mouth Care in the Netherlands US$ 990.00 Sep, 2016 · 20 pages
Calming and Sleeping in the Netherlands US$ 990.00 Apr, 2015 · 22 pages

Ask Your Question

Analgesics in the Netherlands
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: